(Q48587178)

English

Cytogenetic abnormalities in a series of 1,029 patients with primary myelodysplastic syndromes: a report from the US with a focus on some undefined single chromosomal abnormalities

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/18988232

Cytogenetic abnormalities in a series of 1,029 patients with primary myelodysplastic syndromes: a report from the US with a focus on some undefined single chromosomal abnormalities (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/18988232

0 references

author name string

Olga Pozdnyakova

1

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/18988232

Patricia M Miron

2

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/18988232

Guilin Tang

3

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/18988232

Otto Walter

4

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/18988232

Azra Raza

5

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/18988232

Bruce Woda

6

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/18988232

Sa A Wang

7

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/18988232

language of work or name

0 references

publication date

1 December 2008

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/18988232

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/18988232

113

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/18988232

12

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/18988232

3331-3340

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/18988232

A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved outcome

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23977

7 January 2021

based on heuristic

inferred from DOI database lookup

Value of chemotherapy before allogeneic hematopoietic stem cell transplantation from an HLA-identical sibling donor for myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23977

7 January 2021

based on heuristic

inferred from DOI database lookup

Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23977

7 January 2021

based on heuristic

inferred from DOI database lookup

The histone deacetylase (HDAC) inhibitor valproic acid as monotherapy or in combination with all-trans retinoic acid in patients with acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23977

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of myelodysplastic syndromes with valproic acid alone or in combination with all-trans retinoic acid

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23977

7 January 2021

based on heuristic

inferred from DOI database lookup

A multicenter phase 2 study of the farnesyltransferase inhibitor tipifarnib in intermediate- to high-risk myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23977

7 January 2021

based on heuristic

inferred from DOI database lookup

Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: Consensus statements and report from a working conference

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23977

7 January 2021

based on heuristic

inferred from DOI database lookup

World Health Organization classification in combination with cytogenetic markers improves the prognostic stratification of patients with de novo primary myelodysplastic syndromes.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23977

7 January 2021

based on heuristic

inferred from DOI database lookup

Incidence and prognostic significance of karyotype abnormalities in de novo primary myelodysplastic syndromes: a study on 331 patients from a single institution.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23977

7 January 2021

based on heuristic

inferred from DOI database lookup

New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23977

7 January 2021

based on heuristic

inferred from DOI database lookup

The chronic myeloid leukaemias: guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukaemia. Proposals by the French-American-British Cooperative Leukaemia Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23977

7 January 2021

based on heuristic

inferred from DOI database lookup

The World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23977

7 January 2021

based on heuristic

inferred from DOI database lookup

Incidence, characterization and prognostic significance of chromosomal abnormalities in 640 patients with primary myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23977

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical significance of Y chromosome loss in hematologic disease

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23977

7 January 2021

based on heuristic

inferred from DOI database lookup

Hematological malignancies with a deletion of 11q23: cytogenetic and clinical aspects. European 11q23 Workshop participants

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23977

7 January 2021

based on heuristic

inferred from DOI database lookup

Trisomy 19 as the sole chromosomal anomaly in hematologic neoplasms

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23977

7 January 2021

based on heuristic

inferred from DOI database lookup

Isolated isochromosome 17q: a distinct type of mixed myeloproliferative disorder/myelodysplastic syndrome with an aggressive clinical course

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23977

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic significance of single chromosome abnormalities in preleukemic states

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23977

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytogenetic studies in 112 cases of untreated myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23977

7 January 2021

based on heuristic

inferred from DOI database lookup

High-resolution genome-wide array-based comparative genome hybridization reveals cryptic chromosome changes in AML and MDS cases with trisomy 8 as the sole cytogenetic aberration

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23977

7 January 2021

based on heuristic

inferred from DOI database lookup

High incidence of somatic mutations in the AML1/RUNX1 gene in myelodysplastic syndrome and low blast percentage myeloid leukemia with myelodysplasia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23977

7 January 2021

based on heuristic

inferred from DOI database lookup

Correlation of N-ras point mutations with specific chromosomal abnormalities in primary myelodysplastic syndrome.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23977

7 January 2021

based on heuristic

inferred from DOI database lookup

CEBPA point mutations in hematological malignancies

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23977

7 January 2021

based on heuristic

inferred from DOI database lookup

An identical translocation between chromosome 1 and 7 in three patients with myelofibrosis and myeloid metaplasia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23977

7 January 2021

based on heuristic

inferred from DOI database lookup

Unbalanced 1;7 translocation and therapy-induced hematologic disorders: a possible relationship

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23977

7 January 2021

based on heuristic

inferred from DOI database lookup

Unbalanced 1;7 translocation in myelodysplastic syndrome following treatment of acute myeloblastic leukemia with an 8;21 translocation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23977

7 January 2021

based on heuristic

inferred from DOI database lookup

Derivative (1;7)(q10;p10) in multiple myeloma. A sign of therapy-related hidden myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23977

7 January 2021

based on heuristic

inferred from DOI database lookup

The unbalanced 1;7 translocation in de novo myelodysplastic syndrome and its clinical implication

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23977

7 January 2021

based on heuristic

inferred from DOI database lookup

Unbalanced translocation der(1;7)(q10;p10) defines a unique clinicopathological subgroup of myeloid neoplasms

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23977

7 January 2021

based on heuristic

inferred from DOI database lookup

Hypocellularity in myelodysplastic syndrome is an independent factor which predicts a favorable outcome.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23977

7 January 2021

based on heuristic

inferred from DOI database lookup

Survival advantage with decitabine versus intensive chemotherapy in patients with higher risk myelodysplastic syndrome: comparison with historical experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23977

7 January 2021

based on heuristic

inferred from DOI database lookup

CDKN2B methylation status and isolated chromosome 7 abnormalities predict responses to treatment with 5-azacytidine

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23977

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase 2 study of lenalidomide in transfusion-dependent, low-risk, and intermediate-1 risk myelodysplastic syndromes with karyotypes other than deletion 5q.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23977

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.23977

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/18988232

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/18988232

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48587178&oldid=2202683620"